A purified recombinant lipopeptide as adjuvant for cancer immunotherapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Song, Ying Chyi ^a   Liu, Hsueh Hung ^a   Chen, I Hua ^a   Chen, Hsin Wei ^a,b   Chong, Pele ^a,b   Leng, Chih Hsiang ^a,b   Liu, Shih Jen ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2; INTERLEUKIN 5; LIPOPEPTIDE; LIPOPROTEIN; N TERMINAL FRAGMENT OF THE RECOMBINANT LIPOPROTEIN; PEPTIDE VACCINE; PROTEIN E7; RECOMBINANT E7M PROTEIN; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; SUBUNIT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HELPER CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNIZATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; T LYMPHOCYTE; TUMOR IMMUNITY; UTERINE CERVIX CANCER; ANIMAL; C57BL MOUSE; CELLULAR IMMUNITY; IMMUNOLOGY; IMMUNOTHERAPY; PROCEDURES; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOTHERAPY; INTERLEUKIN-2; INTERLEUKIN-5; LIPOPEPTIDES; MICE; MICE, INBRED C57BL; PAPILLOMAVIRUS E7 PROTEINS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS; VACCINES, SUBUNIT;

EID: 84897518877     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/349783     Document Type: Article

References (38)

1. Gearing A. J., Targeting Toll-like receptors for drug development: a summary of commercial approaches. Immunology & Cell Biology 2007 85 6 490 494 2-s2.0-34548443465 10.1038/sj.icb.7100102 (Pubitemid 47367512)
2. Iwasaki A., Medzhitov R., Toll-like receptor control of the adaptive immune responses. Nature Immunology 2004 5 10 987 995 2-s2.0-5444262511 10.1038/ni1112 (Pubitemid 41057715)
3. Lahiri A., Das P., Chakravortty D., Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine 2008 26 52 6777 6783 2-s2.0-56649108016 10.1016/j.vaccine.2008.09.045
4. West A. P., Koblansky A. A., Ghosh S., Recognition and signaling by Toll-like receptors. Annual Review of Cell and Developmental Biology 2006 22 409 437 2-s2.0-33751172758 10.1146/annurev.cellbio.21.122303.115827
5. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R. T., Medzhitov R., Fikrig E., Flavell R. A., Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nature Medicine 2002 8 8 878 884 2-s2.0-0036344106 10.1038/nm732
6. Revets H., Pynaert G., Grooten J., De Baetselier P., Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. The Journal of Immunology 2005 174 2 1097 1103 2-s2.0-11844276029 (Pubitemid 40094307)
7. Shimizu T., Kida Y., Kuwano K., A triacylated lipoprotein from Mycoplasma genitalium activates NF- B through Toll-like receptor 1 (TLR1) and TLR2. Infection and Immunity 2008 76 8 3672 3678 2-s2.0-48849092221 10.1128/IAI.00257-08
8. Tawaratsumida K., Furuyashiki M., Katsumoto M., Fujimoto Y., Fukase K., Suda Y., Hashimoto M., Characterization of N-terminal structure of TLR2-activating lipoprotein in Staphylococcus aureus. The Journal of Biological Chemistry 2009 284 14 9147 9152 2-s2.0-66149125243 10.1074/jbc.M900429200
9. Thakran S., Li H., Lavine C. L., Miller M. A., Bina J. E., Bina X. R., Re F., Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. The Journal of Biological Chemistry 2008 283 7 3751 3760 2-s2.0-42949086603 10.1074/jbc.M706854200
10. BenMohamed L., Gras-Masse H., Tartar A., Daubersies P., Brahimi K., Bossus M., Thomas A., Druilhe P., Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. European Journal of Immunology 1997 27 5 1242 1253 2-s2.0-0030959609 (Pubitemid 27197230)
11. Buwitt-Beckmann U., Heine H., Wiesmuller K.-H., Jung G., Brock R., Akira S., Ulmer A. J., TLR1- and TLR6-independent recognition of bacterial lipopeptides. The Journal of Biological Chemistry 2006 281 14 9049 9057 2-s2.0-33646933064 10.1074/jbc.M512525200 (Pubitemid 43864617)
12. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R. L., Akira S., Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. The Journal of Immunology 2002 169 1 10 14 2-s2.0-0036644042 (Pubitemid 34686113)
13. Akira S., Mammalian Toll-like receptors. Current Opinion in Immunology 2003 15 1 5 11 2-s2.0-0037290876 10.1016/S0952-7915(02)00013-4 (Pubitemid 35454185)
14. Farhat K., Riekenberg S., Heine H., Debarry J., Lang R., Mages J., Buwitt-Beckmann U., Röschmann K., Jung G., Wiesmüller K.-H., Ulmer A. J., Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. Journal of Leukocyte Biology 2008 83 3 692 701 2-s2.0-43349087755 10.1189/jlb.0807586 (Pubitemid 351966879)
15. Leng C.-H., Chen H.-W., Chang L.-S., Liu H.-H., Liu H.-Y., Sher Y.-P., Chang Y.-W., Lien S.-P., Huang T.-Y., Chen M.-Y., Chou A.-H., Chong P., Liu S.-J., A recombinant lipoprotein containing an unsaturated fatty acid activates NF- B through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide. Molecular Immunology 2010 47 11-12 2015 2021 2-s2.0-77953615581 10.1016/j.molimm.2010.04.012
16. Kiura K., Kataoka H., Yasuda M., Inoue N., Shibata K.-I., The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. FEMS Immunology & Medical Microbiology 2006 48 1 44 55 2-s2.0-33748608315 10.1111/j.1574-695X. 2006.00119.x (Pubitemid 44379219)
17. Infante-Duarte C., Kamradt T., Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in α β T-cell receptor transgenic mice. Infection and Immunity 1997 65 10 4094 4099 2-s2.0-0030753414 (Pubitemid 27422064)
18. Cottalorda A., Mercier B. C., Mbitikon-Kobo F. M., Arpin C., Teoh D. Y. L., McMichael A., Marvel J., Bonnefoy-Bérard N., TLR2 engagement on memory CD8+ T cells improves their cytokine-mediated proliferation and IFN- γ secretion in the absence of Ag. European Journal of Immunology 2009 39 10 2673 2681 2-s2.0-70350523613 10.1002/eji.200939627
19. Cottalorda A., Verschelde C., Marcais A., Tomkowiak M., Musette P., Uematsu S., Akira S., Marvel J., Bonnefoy-Berard N., TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. European Journal of Immunology 2006 36 7 1684 1693 2-s2.0-33746256898 10.1002/eji.200636181 (Pubitemid 44089036)
20. Ghielmetti M., Zwicker M., Ghielmetti T., Simon M. M., Villiger P. M., Padovan E., Synthetic bacterial lipopeptide analogs facilitate naive CD4+ T cell differentiation and enhance antigen-specific HLA-II-restricted responses. European Journal of Immunology 2005 35 8 2434 2442 2-s2.0-22644447190 10.1002/eji.200526241 (Pubitemid 41179764)
21. Prajeeth C. K., Jirmo A. C., Krishnaswamy J. K., Ebensen T., Guzman C. A., Weiss S., Constabel H., Schmidt R. E., Behrens G. M. N., The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. European Journal of Immunology 2010 40 5 1272 1283 2-s2.0-77951726803 10.1002/eji.200939790
22. Chen H.-W., Liu S.-J., Liu H.-H., Kwok Y., Lin C.-L., Lin L.-H., Chen M.-Y., Tsai J.-P., Chang L.-S., Chiu F.-F., Lai L.-W., Lian W.-C., Yang C.-Y., Hsieh S.-Y., Chong P., Leng C.-H., A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design. Vaccine 2009 27 9 1400 1409 2-s2.0-59649116879 10.1016/j.vaccine.2008.12.043
23. Kwok Y., Sung W.-C., Lin A. L., Liu H.-H., Chou F. A.-H., Hsieh S. S.-Y., Leng C.-H., Chong P., Rapid isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis. Proteomics 2011 11 13 2620 2627 2-s2.0-79959705422 10.1002/pmic.201000688
24. Huang C. Y., Chen J. J., Shen K. Y., Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model. PLoS ONE 2012 7 7 e40970
25. Mercier B. C., Cottalorda A., Coupet C.-A., Marvel J., Bonnefoy-Bérard N., TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. The Journal of Immunology 2009 182 4 1860 1867 2-s2.0-61449121028 10.4049/jimmunol.0801167
26. Lien E., Sellati T. J., Yoshimura A., Flo T. H., Rawadi G., Finberg R. W., Carroll J. D., Espevik T., Ingalls R. R., Radolf J. D., Golenbock D. T., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. The Journal of Biological Chemistry 1999 274 47 33419 33425 2-s2.0-0033585011 10.1074/jbc.274.47.33419 (Pubitemid 129511647)
27. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M., Muhlradt P. F., Akira S., Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. The Journal of Immunology 2000 164 2 554 557 2-s2.0-0034670021 (Pubitemid 30043671)
28. Morr M., Takeuchi O., Akira S., Simon M. M., Muhlradt P. F., Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. European Journal of Immunology 2002 32 12 3337 3347 (Pubitemid 36024371)
29. Muller S. D., Muller M. R., Huber M., Esche U. V. D., Kirschning C. J., Wagner H., Bessler W. G., Mittenbühler K., Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties. International Immunopharmacology 2004 4 10-11 1287 1300 2-s2.0-4143087182 10.1016/j.intimp. 2004.04.012 (Pubitemid 39094403)
30. Bessler W. G., Baier W., vd Esche U., Hoffmann P., Heinevetter L., Wiesmüller K. H., Jung G., Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization. Behring Institute Mitteilungen 1997 98 390 399 2-s2.0-0031063126
31. Bessler W. G., Mittenbuhler K., Esche U., Huber M., Lipopeptide adjuvants in combination treatment. International Immunopharmacology 2003 3 8 1217 1224 2-s2.0-0037970394 10.1016/S1567-5769(03)00027-4 (Pubitemid 36830862)
32. Cataldi A., Yevsa T., Vilte D. A., Schulze K., Castro-Parodi M., Larzábal M., Ibarra C., Mercado E. C., Guzmán C. A., Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant. Vaccine 2008 26 44 5662 5667 2-s2.0-52949113396 10.1016/j.vaccine.2008.07.027
33. Deres K., Schild H., Wiesmuller K.-H., Jung G., Rammensee H.-G., In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989 342 6249 561 564 2-s2.0-0024389666 10.1038/342561a0 (Pubitemid 20005823)
34. Kerber-Momot T., Leemhuis D., Luhrmann A., Munder A., Tümmler B., Pabst R., Tschernig T., Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa. Inflammation 2010 33 1 58 64 2-s2.0-76149116504 10.1007/s10753-009-9158-7
35. Schild H., Deres K., Wiesmuller K.-H., Jung G., Rammensee H.-G., Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. European Journal of Immunology 1991 21 11 2649 2654 2-s2.0-0026091287
36. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588 (Pubitemid 28155090)
37. Moser M., Murphy K. M., Dendritic cell regulation of TH1-TH2 development. Nature Immunology 2000 1 3 199 205 2-s2.0-0034278725
38. Umeshappa C. S., Xie Y., Xu S., Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways. PLoS ONE 2013 8 6 e64787 10.1371/journal.pone. 0064787